Semaglutide is a synthetic peptide analogue of human GLP-1 designed for research applications involving glucagon-like peptide-1 receptor agonism. It is widely studied for its effects on metabolic pathways, insulin secretion modulation, and receptor signaling in controlled laboratory settings. This high-purity peptide is manufactured under strict quality control standards to ensure consistency and reliability for advanced research use only. Not for human or veterinary use.
